Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / The 4th China Intl Import Expo

    Top executives weigh in at CIIE (IV)

    chinadaily.com.cn | Updated: 2021-11-11 06:40
    Share
    Share - WeChat

    Anna Van Acker, president of MSD in China

    A1: On our third year, leveraging CIIE's unique platform, we enhance communication, sharing, and jointly respond to global public health threats with Chinese partners. Showcase our extensive products, R&D pipeline, innovative medical solutions, and our long-term commitment to benefiting Chinese patients and customers. China has always been a key market for MSD. Adhering to our mission of "Inventing for Life", we continuously bring more innovative and life-saving drugs as well as advanced vaccines to China to better benefit Chinese patients and the public, and support to achieve the "Healthy China 2030" initiative.

    A2: The CIIE provides impetus to the recovery of international exchange, providing opportunities and communication platforms for the multinational companies in China across industries. With the pandemic, global attention to vaccines and infectious disease prevention and control has been much higher than before. As a global leader in the vaccine industry, MSD will continue fulfilling our commitment by promoting innovation and improving medicine accessibility and affordability to benefit Chinese patients and consumers. At this year's CIIE, MSD introduce the first oral antiviral drug, Molnupiravir, if approved by FDA.

    A3: MSD welcomes China's efforts in accelerating the review and approval of innovative medicines and vaccines to benefit Chinese patients. For example, National Medical Product Administration has installed a fast-track review mechanism. CIIE itself serves as an epitome of China's efforts to improve import, which allows all the players to showcase their most innovative products across different industries.

    A4: With health being a main subject of attention today, MSD is pleased to see the recent rapid development of China's pharmaceutical industry regarding R&D talent, scientific research capabilities, investments, business and policy environment.

    As an active participant and builder of the China's health market, MSD is thrilled to join a more mature and diversified consumer market today, which is conducive to the long-term development of MSD in China. Together with local partners, we will bring more vaccines and health solutions to benefit more Chinese consumers for the improvement of public health in China.

    A5: China's reform and opening-up has achieved remarkable results, as recognized by the international community. For example, a lot of efforts have been made in improving the business environment of the pharmaceutical industry, which allows companies to introduce life-saving medicines and innovative vaccines to China at a faster rate. We look forward to higher-level opening-up to facilitate the realization of "Healthy China 2030."

    The continuous optimization of China's business environment has strengthened our confidence in the sustainable development of MSD in China. We will seize the opportunities and continue to work with the government, the institutions and our business partners to meet the unmet medical needs of Chinese patients and the public.

    A6: China's opening-up has optimized the business environment and attracted players around the world. At the same time, more Chinese enterprises are branching out, which contributed to increased flow of ideas, talent and a more diverse business ecosystem.

    A8: Compared with some other countries, how does China's firm support for free trade and multilateralism fare?

    The world has been facing common health challenges that require all stakeholders to come together and work out tangible solutions. Encouragement of collaborations will be conducive to saving and improving lives around the world.

    |<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    а中文在线天堂| 91精品无码久久久久久五月天| 日韩人妻无码精品久久久不卡| 无码中文字幕av免费放dvd| 久久人妻少妇嫩草AV无码专区| 炫硕日本一区二区三区综合区在线中文字幕| 国产在线无码视频一区二区三区| 日本一区二区三区不卡视频中文字幕| 无码8090精品久久一区| 人妻少妇偷人精品无码| 高潮潮喷奶水飞溅视频无码| 久久精品aⅴ无码中文字字幕不卡| 国产午夜精品无码| 亚洲av无码一区二区三区网站| 亚洲不卡无码av中文字幕| 日韩精品无码一区二区中文字幕| a最新无码国产在线视频| 亚洲国产精品无码久久久不卡 | 无码人妻少妇色欲AV一区二区| 国产欧美日韩中文字幕| 中文字幕Av一区乱码| 亚洲av中文无码| 日产无码1区2区在线观看| 99国产精品无码| 国产精品va无码一区二区| 国模GOGO无码人体啪啪| 久久久久亚洲av无码专区喷水| 无码成人一区二区| 性无码免费一区二区三区在线| 永久免费av无码网站yy| 久久AV高潮AV无码AV| 免费一区二区无码东京热| 中文字幕永久一区二区三区在线观看 | mm1313亚洲国产精品无码试看| 欧洲无码一区二区三区在线观看| 人禽无码视频在线观看| 少妇精品无码一区二区三区| 日日摸日日碰夜夜爽无码| 久久精品国产亚洲AV无码偷窥| 国产成人无码综合亚洲日韩 | 变态SM天堂无码专区|